Tezampanel Anhydrous

Tezampanel Anhydrous

SCHEMBL5508469

O.O=C(O)C1CC2CC(CCc3nnn[nH]3)CCC2CN1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5

The experimentally established mechanism targets of Tezampanel Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRIA1 known ✓ P42261 3/20 0.64
GRIA2 known ✓ P42262 3/20 0.64
GRIA3 known ✓ P42263 3/20 0.64
GRIA4 known ✓ P48058 3/20 0.64
GRIK1 known ✓ P39086 1/20 0.64
GRIN2D O15399 2/20 0.64
GRIN3B O60391 2/20 0.64
GRIN1 Q05586 2/20 0.64
GRIN2A Q12879 2/20 0.64
GRIN2B Q13224 2/20 0.64
GRIN2C Q14957 2/20 0.64
GRIN3A Q8TCU5 2/20 0.64
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tezampanel Anhydrous SCHEMBL3677003 0.99 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4GRIN2D
Tezampanel Anhydrous SCHEMBL13320011 0.99 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4GRIN2D
Tezampanel Anhydrous SCHEMBL3688366 0.99 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4GRIN2D
Tezampanel Anhydrous SCHEMBL3227089 0.99 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4GRIN2D
Tezampanel Anhydrous SCHEMBL3688367 0.99 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4GRIN2D
Tezampanel Anhydrous SCHEMBL29227429 0.99 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL14179393 0.89 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL2783303 0.87 GRIA2 (0.64) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8867563 0.87 GRIA2 (0.64) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL20553364 0.87 GRIA2 (0.64) GRIA1GRIA2GRIA3GRIA4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1511741-B1 ESTER DERIVATIVES OF A DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AS ANALGESTICS LILLY CO ELI (US) 2012-12-26 EP disclosed
US-7247644-B2 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics ELI LILLY AND COMPANY (US) 2007-07-24 US disclosed
US-20050256155-A1 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics ELI LILLY AND COMPANY (US) 2005-11-17 US disclosed
EP-1511741-A1 ESTER DERIVATIVES OF A DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AS ANALGESTICS ELI LILLY AND COMPANY (US) 2005-03-09 EP disclosed
WO-2003091243-A1 ESTER DERIVATIVES OF A DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AS ANALGESTICS ELI LILLY AND COMPANY (US) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256155-A1 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics FAAH, FAAH2, GRIK5 GRIA1 203/4885GRIA2 308/4885GRIA3 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.